Cas no 307531-84-6 (Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]-)
Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]- Chemical and Physical Properties
Names and Identifiers
-
- Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]-
- 5-(1,3-DIOXOLAN-2-YL)-2-THIENYLZINC BROMIDE,
- bromozinc(1+),2-(2H-thiophen-2-id-5-yl)-1,3-dioxolane
- 5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide 0.5 M in Tetrahydrofuran
- 5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide solution
- 533696_ALDRICH
- 5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide, 0.5M in tetrahydrofuran
- Zinc, bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]-
- MFCD02260130
- 5-(1,3-dioxolan-2-yl)-2-thienylzinc bromide
- bromozinc(1+);2-(2H-thiophen-2-id-5-yl)-1,3-dioxolane
- 307531-84-6
- AKOS016017872
- BROMO[5-(1,3-DIOXOLAN-2-YL)THIOPHEN-2-YL]ZINC
-
- MDL: MFCD02260130
- Inchi: 1S/C7H7O2S.BrH.Zn/c1-2-6(10-5-1)7-8-3-4-9-7;;/h1-2,7H,3-4H2;1H;/q-1;;+2/p-1
- InChI Key: DZNBTCXRFDXCFM-UHFFFAOYSA-M
- SMILES: Br[Zn+].S1[C-]=CC=C1C1OCCO1
Computed Properties
- Exact Mass: 297.86400
- Monoisotopic Mass: 297.86415g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 190
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: nothing
- Topological Polar Surface Area: 43.8?2
Experimental Properties
- Color/Form: Black liquid
- Density: 1.017?g/mL?at 25?°C
- Melting Point: 228-230℃
- Boiling Point: 65?°C
- Flash Point: Fahrenheit: 1.4 ° f < br / > Celsius: -17 ° C < br / >
- PSA: 46.70000
- LogP: 2.43680
- Solubility: Not determined
- Color/Form: 0.5?M in THF
Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]- Security Information
-
Symbol:
- Signal Word:Danger
- Hazard Statement: H225-H302-H319-H335-H351
- Warning Statement: P210-P280-P301+P312+P330-P305+P351+P338-P370+P378-P403+P235
- Hazardous Material transportation number:UN 2056 3/PG 2
- WGK Germany:3
- Hazard Category Code: 11-19-36/37-40
- Safety Instruction: S16; S26; S33; S36/37
-
Hazardous Material Identification:
- Storage Condition:2-8°C
- Risk Phrases:R11; R19; R20/21/22; R36/37/38
Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 533696-50ML |
Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]- |
307531-84-6 | 0.5M in THF | 50ML |
¥2251.91 | 2022-02-24 | |
| Fluorochem | 213944-50ml |
5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide 0.5 M in Tetrahydrofuran |
307531-84-6 | 50ml |
£334.00 | 2022-03-01 | ||
| abcr | AB361354-50 ml |
5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide, 0.5M in tetrahydrofuran; . |
307531-84-6 | 50 ml |
€558.90 | 2024-04-17 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D920288-50ml |
5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide solution |
307531-84-6 | 0.5 M in THF | 50ml |
¥1,929.60 | 2022-01-11 | |
| abcr | AB361354-100 ml |
5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide, 0.5M in tetrahydrofuran; . |
307531-84-6 | 100 ml |
€1288.30 | 2024-04-17 | ||
| A2B Chem LLC | AB41304-50ml |
Zinc, bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]- |
307531-84-6 | 50ml |
$383.00 | 2024-04-20 | ||
| abcr | AB361354-50ml |
5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide, 0.5M in tetrahydrofuran; . |
307531-84-6 | 50ml |
€558.90 | 2025-02-18 | ||
| abcr | AB361354-100ml |
5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide, 0.5M in tetrahydrofuran; . |
307531-84-6 | 100ml |
€1288.30 | 2025-02-18 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | J20_213944-50ml |
5-(1,3-Dioxolan-2-yl)-2-thienylzinc bromide 0.5 M in Tetrahydrofuran |
307531-84-6 | nan | 50ml |
¥7348.00 | 2025-04-15 |
Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]- Related Literature
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
Additional information on Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]-
Introduction to Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] and Its Applications in Modern Chemical Biology
Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] is a fascinating compound characterized by its unique molecular structure and potential applications in the field of chemical biology. The compound's chemical formula and CAS number, CAS no. 307531-84-6, provide a precise identifier for researchers and manufacturers alike. The presence of bromo and 1,3-dioxolan-2-yl substituents in the molecule suggests a rich chemical reactivity that could be exploited for various biological and pharmaceutical purposes.
The Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] moiety combines the versatility of zinc-based coordination chemistry with the structural features of thienyl and dioxolan rings. These elements have been extensively studied for their role in enhancing the bioactivity of molecules. The bromine atom, in particular, serves as a versatile handle for further functionalization through cross-coupling reactions, which are pivotal in modern drug discovery.
Recent advancements in synthetic chemistry have highlighted the importance of such heterocyclic compounds in developing novel therapeutic agents. The 1,3-dioxolan-2-yl ring is known for its stability and ability to participate in various organic transformations, making it an attractive scaffold for medicinal chemists. When combined with the thienyl group, which is commonly found in biologically active natural products, the resulting compound exhibits intriguing pharmacological properties.
One of the most promising areas of research involving Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] is its potential as a precursor for small-molecule inhibitors targeting specific biological pathways. For instance, studies have shown that thienyl-containing compounds can interact with enzymes and receptors in ways that modulate inflammatory responses and cell proliferation. The bromo substituent allows for further derivatization via palladium-catalyzed cross-coupling reactions, enabling the construction of more complex structures with tailored biological activities.
In the realm of drug development, the ability to precisely control molecular architecture is crucial for achieving desired pharmacokinetic and pharmacodynamic profiles. The synthesis of Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] exemplifies this trend towards rational molecular design. By leveraging well-established synthetic methodologies, researchers can efficiently access this compound and its derivatives, facilitating high-throughput screening and lead optimization.
Moreover, the compound's structural features make it a valuable tool for studying metalloprotein interactions. Zinc ions are essential cofactors for numerous enzymes involved in critical biological processes. The coordination of zinc with organic ligands like Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] can provide insights into how metal ions regulate enzyme function and may inspire the design of novel therapeutic strategies.
Emerging research also suggests that Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] could play a role in materials science applications beyond biology. Its unique electronic properties make it a candidate for use in organic electronics, where thienyl-containing materials are increasingly employed due to their stability and conductivity. By exploring these interdisciplinary applications, scientists can uncover new possibilities for this versatile compound.
The development of new synthetic routes has further enhanced the accessibility of Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl], enabling its widespread use in academic and industrial research. Techniques such as transition-metal catalysis and flow chemistry have streamlined the synthesis process, allowing for scalable production without compromising purity or yield. This accessibility is crucial for advancing research projects that rely on this compound as a key building block.
As our understanding of molecular interactions continues to grow, compounds like Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl] will undoubtedly play a significant role in shaping the future of chemical biology. Their unique structural features and reactivity make them indispensable tools for researchers seeking to unravel complex biological mechanisms and develop innovative therapeutics. The continued exploration of such molecules promises to yield groundbreaking discoveries that will impact human health and disease treatment.
307531-84-6 (Zinc,bromo[5-(1,3-dioxolan-2-yl)-2-thienyl]-) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)